Related Experiment Video

Updated: Jul 17, 2026

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of

Hitomi Kataoka Usui1, Kenichi Shikata, Motofumi Sasaki

  • 1Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

Diabetes
|January 30, 2007
PubMed

Insights

Macrophage scavenger receptor-A (SR-A) deficiency reduced kidney inflammation and damage in diabetic mice. SR-A promotes macrophage migration, suggesting it

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Biology

Background:

  • Diabetic nephropathy involves microinflammation and macrophage infiltration.
  • Macrophage scavenger receptor-A (SR-A) is implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the role of SR-A in the pathogenesis of diabetic nephropathy.
  • To assess the therapeutic potential of targeting SR-A in diabetic kidney disease.

Main Methods:

  • Streptozotocin-induced diabetes in SR-A-deficient (SR-A(-/-)) and wild-type (SR-A(+/+)) mice.
  • Evaluation of renal pathology, albuminuria, gene expression, and macrophage infiltration.
  • In vitro assessment of monocyte adhesion to extracellular matrix components.

Main Results:

  • Diabetic SR-A(-/-) mice showed significantly reduced albuminuria, glomerular hypertrophy, and mesangial expansion compared to diabetic SR-A(+/+) mice.
  • Macrophage infiltration and proinflammatory gene expression were markedly decreased in the kidneys of diabetic SR-A(-/-) mice.
  • SR-A blockade inhibited monocyte attachment to type IV collagen, suggesting a role in macrophage migration.

Conclusions:

  • SR-A plays a critical role in promoting macrophage infiltration into the kidneys during diabetic nephropathy.
  • Targeting SR-A may offer a novel therapeutic strategy for diabetic vascular complications, particularly diabetic nephropathy.

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...